25990-10-7

25990-10-7 structure
25990-10-7 structure
  • Name: Polygalacturonic acid
  • Chemical Name: D-Galacturonic acid
  • CAS Number: 25990-10-7
  • Molecular Formula: C6H10O7
  • Molecular Weight: 194.139
  • Catalog: Research Areas Infection
  • Create Date: 2018-05-16 10:05:15
  • Modify Date: 2025-08-27 17:37:11
  • Polygalacturonic acid (Galacturonic acid polymer) is transparent colloid, is a major component of the cell wall. Polygalacturonic acid can be used to prepare silver nanoparticles (AgNPs), as an antioxidant and anti-inflammatory that protect cells from destructive effect of elevated ROS and accelerate wound healing. Polygalacturonic acid nanoparticles also displays anti-bacterial activity[1][2].

Name D-Galacturonic acid
Synonyms DL-Galacturonic acid
α-D-Galacturonic acid
MFCD00131972
D-Galacturonic acid (9CI)
D-Galacturonic acid
δ-Galacturonic acid
Description Polygalacturonic acid (Galacturonic acid polymer) is transparent colloid, is a major component of the cell wall. Polygalacturonic acid can be used to prepare silver nanoparticles (AgNPs), as an antioxidant and anti-inflammatory that protect cells from destructive effect of elevated ROS and accelerate wound healing. Polygalacturonic acid nanoparticles also displays anti-bacterial activity[1][2].
Related Catalog
In Vitro Polygalacturonic acid can be used to format a durable hydrogel, to prolong the effect of drugs. Polygalacturonic acid hydrogel/hyaluronate, conjugated Ibuprofen (HY-78131) for example, prevents epidural fibrosis, the severe scar tissue adhesion of laminectomized male adult rats, and increases the efficiency of local inflammation control and reduces the side-effect of Ibuprofen[1]. Polygalacturonic acid hydrogel/hyaluronate (PGA-HA) (2%, 200 μL; 24 h) shows low cytotoxicity on L929 fibroblasts[1]. Polygalacturonic acid (PGA) preparing (Ag-PGA/HA)-PVA nanoparticles, shows anti-bacterial activity against gram-positive bacterial strains; Bacillus Subtilis and Staphylococcus Aureus, as well as gram-negative bacterial strain; Escherichia Coli[2].
In Vivo Polygalacturonic acid (external application; 14 d) enhances a quick healing of wound infection in albino rats[2]. Animal Model: Full thickness wound model in albino rats (60-day-old, 180 g)[2] Dosage: Ag-Polygalacturonic acid/hyaluronic acid nanoparticles Administration: Applied on dorsal muscle fascia; cleaned the wound daily with alcohol; for 14 days Result: Resulted no sign of abscess formation or hypertrophic scars both in the early phase; 5th day or in the final phase; 14th day, respectively. Showed significant wound healing from day 8 while treated with (Ag-PGA/HA)-PVA nanofiber and blank (PGA/HA)-PVA nanofiber and induced epithelization on day 14.
References

[1]. Lin CY, et al. Ibuprofen-conjugated hyaluronate/polygalacturonic acid hydrogel for the prevention of epidural fibrosis. J Biomater Appl. 2016 May;30(10):1589-600.

[2]. El-Aassar MR, et al. Wound healing of nanofiber comprising Polygalacturonic/Hyaluronic acid embedded silver nanoparticles: In-vitro and in-vivo studies. Carbohydr Polym. 2020 Jun 15;238:116175. 

Density 1.7±0.1 g/cm3
Boiling Point 553.4±50.0 °C at 760 mmHg
Molecular Formula C6H10O7
Molecular Weight 194.139
Flash Point 302.6±26.6 °C
Exact Mass 194.042648
LogP -1.49
Vapour Pressure 0.0±3.4 mmHg at 25°C
Index of Refraction 1.592
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xi
RIDADR NONH for all modes of transport
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.